Application | Comment | Organism |
---|---|---|
medicine | potential drug target, antimalarial drugs | Plasmodium falciparum |
Cloned (Comment) | Organism |
---|---|
into pET29b and pET22b vector for expression in Escherichia coli BL21(DE3) cells | Plasmodium falciparum |
Crystallization (Comment) | Organism |
---|---|
2.2 A, cocrystallized with a synthesized inhibitor - 2.8 A resolution of the unliganded PfPDF | Plasmodium falciparum |
Protein Variants | Comment | Organism |
---|---|---|
Ndelta57PfPDF Cdelta234 | PfPDF variant with truncations of the first aminoterminal 57 acid residues and carboxyl terminus to amino acid residue S234 | Plasmodium falciparum |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
formyl-L-methionyl peptide + H2O | Plasmodium falciparum | - |
formate + methionyl peptide | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Purification (Comment) | Organism |
---|---|
purified by cation exchange chromatography followed by Co-NTA affinity column chromatography | Plasmodium falciparum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
formyl-L-methionyl peptide + H2O | - |
Plasmodium falciparum | formate + methionyl peptide | - |
? |
Synonyms | Comment | Organism |
---|---|---|
peptide deformylase | - |
Plasmodium falciparum |
PfPDF | - |
Plasmodium falciparum |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6 | - |
for purified and modified PfPDF | Plasmodium falciparum |